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Recommended by Mario Maggi
Leptin, like estrogen, is one of the endo/paracrine factors, which are synthesized in and secreted from mature adipocytes. The
roles of the mammary fat pad and mammary adipocytes in the initiation of lactation are not clear. In this study, we showed that
combination of prolactin, leptin and estrogen elevated the expression of the milk protein beta-lactoglobulin. We also showed that
after prolactin stimulate the secretion of leptin from the mammary fat, leptin upregulated the expression of estrogen receptor
alpha in the mammary epithelial cells. Also, prolactin aﬀected aromatase mRNA expression in the bovine mammary fat and we
demonstrated that leptin and prolactin can aﬀect cholesterol secretion from explants in culture to the medium. Therefore, we
suggest that prolactin initiates estrogen expression (as represented by aromatase mRNA) in the mammary fat pad, whereas leptin
stimulates estrogen receptor alpha expression in the mammary epithelial cells. We hypothesize that leptin and estrogen, secreted
from the mammary fat regulate lactation after stimulation of prolactin.
Copyright © 2009 Yonatan Feuermann et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Traditionally, the function of the adipose tissue is regarded
as energy storage. However, recent studies showed that the
adipose tissue is a highly active endocrine organ, which
synthesizes and secretes a large number of proteins, such
as leptin, resistin, adiponectin, angiotensinogen, and many
others. Some of these proteins induce insulin resistance,
others play a role in glucose and lipid metabolism or even
as a mediators of the immune system [1]. The mammary
fat pad, was considered as an inert matrix, however it is
believed to be a hormone-producing tissue [2–4]. Recent
evidence suggests that the adipocytes-epithelial interaction
is critical for mammary duct growth and morphogenesis
[5, 6]. Generally, estrogen is required for growth and
morphogenesis of the mammary gland in rodents [7]a n d
bovine [8], and it is also essential for mammary epithelial
proliferation and diﬀerentiation [9]. Estrogen receptor alpha
mRNA expression is abundant in the mammary gland
of non-pregnant heifers [10, 11], lactating cows [11]a n d
human [12]. It was shown that the bovine mammary
gland secretes estrogen during the last week of pregnancy
[13], and that estrogen eﬀects are mediated mainly by
estrogen receptor alpha in the mammary gland. Estrogen
receptor alpha expression is limited to the bovine mammary
epithelial cells during pregnancy, lactation and regenerative
involution [11]. Transplantation of epithelial and stroma
cells from estrogen receptor alpha-null mice and wild-
type mice demonstrated that estrogen responsiveness was
mediated by paracrine factors, and that estrogen receptor
alpha responses varied with the developmental stage of the
mammary gland [14].
The role of leptin in the regulation of bovine lactation is
not clear. Leptin has been found in mammary adipocytes of
sheep during the early phase of pregnancy, and in mammary
epithelial cells during lactation [15]. The leptin receptor is a
member of the class I cytokine receptor family, and is present
in ﬁve diﬀerent spliced forms: Ob-Ra, Ob-Rb, Ob-Rc, Ob-
Rd,andOb-Re[16].Thetissuedistributionofleptinreceptor
isoforms in bovine is not well established. The expression2 International Journal of Endocrinology
of Ob-Ra has been reported previously only in the adrenal
gland[17],pituitarygland,liverandspleenincattle[18],and
in the lactating ovine mammary gland [19]. Previously we
demonstrated that leptin alone had no eﬀect on alpha casein
gene expression and fatty acid synthesis in bovine mammary
explants, nonetheless in the presence of prolactin, leptin up-
regulatedalphacaseinandbetalactoglobulinexpression,and
fatty acid synthesis [20]. Leptin is believed to be one of
the markers of matured adipocytes [1]. During the terminal
phase of diﬀerentiation to mature adipocytes, activation
of the transcriptional cascade leads to increased metabolic
activity that converts the adipocyte to a highly specialized
endocrine cell, in which one of the factors is leptin synthesis
and secretion [21]. The lactogenic hormone prolactin is one
of the factors that stimulate adipogenesis in preadipocyte
cell lines and has variable lipolytic and lipogenic eﬀects in
mature adipose tissue [22]. Prolactin had been assumed to
be involved in mammogenesis [6]. Prolactin receptor has
b e e ne x p r e s s e di nt h em a m m a r yg l a n df a tp a di nh u m a n s
[23], and ovine mammary parenchyme [24]. Recent studies
showed that after 5-6 weeks of lactation, the plasma levels
of prolactin begins to rise and short time after, leptin
concentration increased as well [25]. In the current study
we used three diﬀerent culture systems: (a) primary cell
culture that contains mostly mammary epithelial cells, (b)
hind udder fat explants that contain mostly fat cells, and (c)
mammary explants that are the closest in vitro system to
the udder. These in vitro systems allowed us to investigate
whether prolactin interacts with the bovine mammary fat-
driven estrogen and leptin, and to look for the eﬀects of
leptin and estrogen on lactogenic parameters in mammary
gland cells and explants, after stimulation with prolactin.
2.MaterialsandMethods
2.1. Mammary Tissue Collection. Mammary tissue was
obtained from Holstein cows at the slaughterhouse, 2 to
5 months after the onset of lactation. The Israeli Ministry
of Agriculture approved all procedures in accordance with
Israeli regulations for animal experimentation.
2.2. Materials. M-199, penicillin, streptomycin, and Fungi
zone (amphotericin B) were obtained from Bet Haemek,
Israel. Bovine insulin, cortisol, estrogen and ovine prolactin
were purchased from Sigma (St. Louis, MO). Bovine recom-
binant leptin and leptin antagonist were generously given as
a gift from Prof A. Gertler [26].
2.3. Mammary Explants Culture. Mammary tissue were
obtained from 3–5 cows at the slaughterhouse, and were
transferred into medium M-199, containing 100U peni-
cillin, 100μg streptomycin, 0.25μg Fungi zone, and 1μg
insulin (per millliliter). Explants were prepared as previously
described [27]. Twenty explants, 50–80mg total weight from
a one udder quarter, were placed on an impregnated lens
paper ﬂoating in 5mL of M-199 medium, and cultured
at 37◦C in a medium supplemented with insulin at 1μg
mL−1,c o r t i s o la t0 . 5 μgm L −1 and prolactin at various
concentrations (IFP). Or in medium supplemented only
with insulin at 1μgm L −1 and cortisol at 0.5μgm L −1 (IF).
Leptin and leptin antagonist were added according to the
experimental protocol. The medium was changed every 24
hours, for 5 days.
2.4. Fat Explants Cultures. Mammary fat tissue from the
hind udder portion was taken aseptically from cows at
the slaughterhouse and transferred into medium M-199
containing 100U penicillin, 100μg streptomycin, 0.25μg
Fungi zone, and 1μg insulin (per milliliter), as previously
described [28]. Fat tissue explants from a one udder quarter,
were cultured, ﬂoating in 5mL of M-199 medium, at 37◦C
in medium supplemented with insulin at 1μgm L −1, cortisol
at 0.5μgm L −1 and prolactin at various concentrations, or
in medium supplemented only with insulin at 1μgm L −1
and cortisol at 0.5μgm L −1 (basal medium). Leptin and
leptin antagonist were added according to the experimental
protocol. The medium was changed every 24 hours, for 5
days.
2.5. Fat-Epithelial Co-Culture. Bovine mammary-gland tis-
sue was transferred to the laboratory, cut into small pieces
and placed in a 500-mL Erlenmeyer ﬂask containing M-
199 medium supplemented with collagenase at 1mg mL−1,
hyaluronidaseat1mgmL−1 andbovineinsulinat1μgmL −1,
at a ratio of 10mL of supplemented medium to 1g of tissue.
T h ec u l t u r ew a ss w i r l e da t1 0 0 r p mi nag y r a t i n gw a t e r
bath at 37◦C for 3 to 4 hours. During this period, tissue
fragments were further dissociated by occasional aspiration
through a 10-mL pipette with a large oriﬁce. One hour
before termination of the enzymatic digestion, 0.04% DNase
was added at 0.5mL per 100mL of digest. At the end of
the incubation, the suspension was passed through a Nitex
ﬁlter (200μm) and the cells were washed three to ﬁve times
with M-199. The cells were grown in a 10-mm plastic dish
in DMEM/F-12 (HAM) 1 : 1, supplemented with 10%
fetal calf serum (FCS), and (per milliliter) 1μg insulin,
10,000U penicillin, 10mg streptomycin, 0.025mg Fungi
zone and 0.5mg L-glutamine, in a humidiﬁed atmosphere
of 5% CO2/95% air at 37◦C. The medium was changed at
48-h intervals until the end of the experiment. The cells
were grown to conﬂuence, dispersed with 0.05% trypsin,
transferredtonewplates,andstoredat−70◦Cin10%DMSO
and20%FCS.Thecellsusedintheseexperimentsunderwent
no more than six transfers. Once the experiment began, fat
explants were prepared as described in the Explants Culture
sectionandwereaddedtotheprimarymammarycellculture
dish for 48 hours.
2.6. Western Blot Analysis. Western blotting was carried
out according to Schuler et al. [29] with the following
modiﬁcations. Samples (40μg protein in 20μlb u ﬀer) were
boiled in 3x loading buﬀer (10mM Tris–HCl, pH 6.8,
including 3% SDS, 5% mercaptoethanol, 20% glycerol
and 0.6% bromophenol blue for 3 minutes, separated on
12% Bis-Tris gel under reducing conditions for 1 hour
at 190 V, and transferred to nitrocellulose membranesInternational Journal of Endocrinology 3
(Millipore PVDF, 0.45μm; Millipore, Bedford, USA). For
blocking, membranes were incubated overnight in PBS with
0.05% Tween-20 (PBS-T) with 1% non-fat dry milk. The
membranes were then incubated in PBS-T and incubated
for 75 minutes with the respective primary antibody, ER-
alpha rabbit polyclonal IgG (dilution 1 : 200) against
epitope corresponding to amino acids 2–185 mapping at
the amino terminus of human ER alpha (no. sc 7207; Santa
Cruz Biotech, Heidelberg, Germany). After washing in PBS-
T, the membranes were incubated with the horseradish
peroxidase-linked secondary goat anti-mouse or goat anti-
rabbit immunoglobulin antibody (no. sc 7207; Santa Cruz
Biotech) for 45 minutes. At the end, they were again
washedinPBS-T,incubatedinenhancedchemiluminescence
reagents (ECL Western Blotting Analysis System; Amersham
Pharmacia Biotech, Freiburg, Germany) for 30 s or 1 minute.
Blue Plus 2 Pre-Stained Standard (Novex, San Diego, CA,
USA) was used as the molecular size marker.
2.7. Total Cholesterol. In order to determine the total choles-
terolsecretionbytheexplantstothemedium,eightreplicates
of each treatment were collected to form a total of 40mL
of medium. The medium was lyophilized and dissolved in a
chloroform : methanol 2 : 1 (v/v) solution. Total cholesterol
content was determined after saponiﬁcation of 100μlo f
concentrated medium. After extraction in petroleum ether,
colorimetric measurements were done with a modiﬁed
Lieberman–Buchard reaction, as described previously [30].
2.8.IsolationofRNA. TotalRNAwasisolatedfromthemam-
mary tissue by the acid guanidinium thiocyanate phenol-
chloroform extraction method [31]. Following its isolation,
the RNA was kept at −70◦C pending analysis by RT-PCR or
real-time PCR (rt-PCR).
2.9. Reverse Transcription (RT). Total RNA (1 μg) was re-
verse-transcribed in a ﬁnal volume of 20μl containing:
50mM Tris-HCl (pH 8.3), 75mM KCl, 5mM MgCl2,
10mM dithiothreitol, 0.5mM deoxy-NTP (dNTP), 0.5μg
oligo-dT/Hexamer primers (Promega, Madison, WI), and
1U avian myeloblastosis virus (AMV) reverse transcriptase
(Promega). The reaction temperatures were 42◦Cf o r1h o u r
and 95◦Cf o r1 0m i n u t e s .
2.10. Real-Time PCR (rt-PCR). RNA samples were reverse-
transcribed as described. Samples were analyzed by rt-PCR
with the ABI Prism 7000 system (Applied Biosystems, Foster
City, CA). A 5-μls a m p l eo fc D N Aw a sa m p l i ﬁ e df o r4 0c y c l e s
with 3μl of the following primers at a ﬁnal concentration
of 0.5μM: ER-alpha (sense 5 -AGG GGA GCT CCT ATT
TGC TCC-3 , antisense 5 -CGG TGG ATG TGG TCC TTC
TCT-3 ); beta-lactoglobulin (sense 5 -ATC CCT GCG GTG
TTC AAG AT-3 , antisense 5 -CCA TGC AGA CGA GCA
GGT ACT-3 ); aromatase primers (sense 5 -CCG GTC TCT
GGT CTC GTC TG-3 , antisense 5 -TTC TGA GAC GCT
TCC ACG TG-3 ); and as a normalizing control, bovine
ribosomal 18S (sense 5 -CGG CTA CCA CAT CCA AGG
AA-3 , antisense 5 -GGG CCT CGA AAG AGT CCT GT-
3 ). The reaction was carried out in a ﬁnal volume of 50μl,
comprising 16μl of SYBR Green (Applied Biosystems), 3μl
of 5μMp r i m e rm i x ,3 μlo f5 μM reverse primer, 5μlo f
cDNA template and 23μl of deionized water, for 40 cycles
of 1minute of denaturation at 95◦C, 2minutes of annealing
at 60◦C, and 1minute of extension at 72◦C. The ampliﬁed
PCR product was analyzed with ABI Prism 7000 software
(Applied Biosystems). At the end of the rt-PCR run, a
melting curve was determined to verify the presence of a
single amplicon. The analysis of rt-PCR was preformed as
previously described by feuermann et al. [28].
2.11. Statistical Analysis. All statistical analyses were carried
out with the JMP 5.0.1 statistical package from SAS. The
results of the explants experiments, leptin secretion and
expression experiments were compared by one-way ANOVA.
The results of the co-culture experiments were compared
by means of Student’s t-test [32] after one-way ANOVA. In
all the experiments the control was considered as the basal
treatment. (medium containing insulin at 1μgm L −1 and
cortisol at 0.5μgm L −1)
3. Results
3.1. Eﬀects of Leptin, Prolactin and Estrogen on Beta-
Lactoglobulin Expression in Explants from Mammary Glands
of Lactating Cows. Mammary gland explants from lactating
cows were incubated for 4 days in media containing various
treatments of prolactin at 1μgm L −1,l e p t i na t5 0n gm L −1,a
combined treatment of leptin and prolactin, and a combined
treatment prolactin at 1μgm L −1,l e p t i na t5 0 n gm L −1
with estrogen (at 200ng/mL). The expression of beta-
lactoglobulin was evaluated by real-time PCR. As shown in
Figure 1, leptin alone had no eﬀect on beta-lactoglobulin
expression. Medium containing prolactin elevated the beta-
lactoglobulin expression above the control level in a sig-
niﬁcant manner. Addition of leptin to medium containing
prolactin up-regulated the lactogenic eﬀect of prolactin.
Addition of estrogen to medium containing leptin and
prolactin signiﬁcantly augmented the expression of beta-
lactoglobulin to its highest level.
3.2.ExpressionofAromatasemRNAinMammaryFatExplants
and Mammary Primary Culture. The expression of aro-
matase mRNA in fat explants (closed bars) and primary
mammary cells (open bars) from a lactating cow was
analyzed by real time PCR (Figure 2). The co-culture of
cells and fat were incubated with several concentrations
of prolactin (0.01, 0.1, and 1μgm L −1). The expression
of aromatase in a primary cells culture did not change
signiﬁcantly, but was signiﬁcantly elevated in fat explants at
prolactin concentrations of 1μgm L −1: by almost 5.5-fold,
respectively, compared with the control (basal medium).
3.3. Real Time Analysis of ER Alpha in Primary Mammary
Cells from Lactating Cow. Primary mammary cells from













































































Figure 1: Eﬀects of leptin, prolactin, and estrogen on beta-
lactoglobulin expression in explants from mammary glands of lac-
tating cows. Mammary-gland explants from lactating cows were
incubated for 4 days in media containing various treatments:
prolactinat1μgmL −1,leptinat50ngmL −1,acombinationofleptin
and prolactin, and a combination of leptin and estrogen at 200ng
mL−1. Expression of the beta-lactoglobulin gene was evaluated by
real-time PCR. Leptin alone elevated beta-lactoglobulin expression
to a level of 1.2 arbitrary units, a level, which was not signiﬁcantly
diﬀerentfromthatwithinsulinalone.Mediumcontainingprolactin
elevated beta-lactoglobulin expression to a level of 1.8 arbitrary
units. When leptin and prolactin together were added to the
medium, the level of beta-lactoglobulin reached 2.3 arbitrary units.
Addition of estrogen to medium containing leptin and prolactin
augmented the beta-lactoglobulin expression to 2.9 arbitrary units.
Least squares means ± SE (n = 3). Bars with diﬀerent letters diﬀer

















































































Insulin alone = 1
Figure 2: Expression of aromatase mRNA in mammary fat explants
and mammary primary culture. Expression of aromatase mRNA in
fat explants (closed bars) and primary mammary cells (open bars)
fromalactatingcow,withvariousconcentrationsofprolactin(0.01,
0.1 and 1mg mL−1) in the medium. The expression of aromatase
in cultures of primary cells did not change signiﬁcantly. Signiﬁcant
expression of aromatase was observed in fat explants at prolactin
concentrations of 1mg mL−1. Least squares means ± SE (n = 3).
Bars with diﬀerent letters diﬀer at P < .05. ∗, ∗∗means diﬀering
at P < .05 and P < .01, respectively, between treatments with
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Figure 3: Real time analysis of ER alpha in mammary explants
from lactating cow after incubation with diﬀerent levels of leptin.
Explants from a lactating bovine mammary gland were incubated
with several concentrations of leptin (10, 100, and 1000ng mL−1).
ER alpha mRNA expression was up-regulated in a dose-dependent
manner. At a leptin concentration of 10ng mL−1 the expression
of ER alpha reached a level of 1.3 arbitrary units, at 100ng mL−1
leptin elevated ER alpha expression to 1.9 arbitrary units, and at a
leptin concentration of 100ng mL−1 the ER alpha expression level
reached 3 arbitrary units. Least squares means ± SE (n = 3). Bars
with diﬀerent letters diﬀer at P < .05
diﬀerent concentrations of leptin (10, 100, and 1000ng
mL−1) and one concentration of leptin antagonist (3200ng
ml
−1). ER alpha mRNA expression was analyzed by real-time
PCR. As shown in Figure 3, the expression ER alpha was
up-regulated in the presence of leptin in a dose-dependent
manner. Addition of leptin antagonist at a concentration of
3200ng mL−1 to the medium containing leptin at 100ng
mL−1, down-regulated the expression of ER alpha.
3.4. Eﬀect of Prolactin on ER Alpha Expression in Primary
Cell Culture from Mammary Glands of Lactating Cows with
or without Fat Explants. Primary mammary cell culture
and mammary fat explants were incubated with several
concentrations of prolactin (0.01, 0.1 and 1μgm L −1), and
3200ng/mL leptin antagonist in medium containing 1μg
mL−1 prolactin. The primary culture was incubated with
or without mammary fat explants. The expression of ER
alpha in bovine mammary gland primary cultureis shown in
Figure 4. The addition of prolactin to the medium elevated
the level of ER alpha mRNA expression in mammary cells
incubated with mammary fat explants. A level 16 arbitrary
units of ER alpha mRNA expression in the mammary cells
was observed at the prolactin concentration of 1μgm L −1.
Leptin antagonist down regulated the enhancement of ER
alpha expression to a level of 6 arbitrary units of ER alpha
mRNA expression. The expression of ER alpha in primary
culture that were not incubated with fat explants did not
change dramatically (0.8, 1.8, 2.5, and 2.3 arbitrary units
of ER alpha mRNA expression at prolactin concentration
of 0.01, 0.1, 1μgm L −1 in the medium, and 1μg/mL and
3200ng/mL leptin antagonist, resp.). Throughout the exper-












































































Figure 4: The eﬀect of fat explants on ER alpha expression in
bovine mammary gland primary cell culture. The expression of
ER alpha was examined in primary culture that was incubated
with mammary fat explants (closed bars) or without mammary
fat explants (open bars). Four treatments were introduced: three
diﬀerent levels of prolactin (0.01, 0.1, and 1μg/mL) and one
combinedtreatmentofleptinantagonist(3200ng/mL)and1μg/mL
prolactin. The expression of ER alpha in primary culture incubated
with no fat explants did not change in the same magnitude when
compared to explants incubated with fat explants. A signiﬁcant
diﬀerence in the expression of ER alpha between the treatments
containing fat explants and those without was observed at prolactin
concentrations of 0.1 and 1μg/mL prolactin. Leptin antagonist
minimized the diﬀerences between the two treatments (with fat
and without). Results are least square means ± S.E.M. of four
independent experiments (n = 3). ∗, ∗∗ means diﬀering at P <
.05 and P < .001, respectively, between treatments with and without
fat-explants.
containing fat explants relative to the primary culture alone
(basal medium).
3.5. Eﬀects of Prolactin and Leptin on Cholesterol Secretion
to the Culture Medium of Mammary Explants. Mammary
explants from a lactating cow were incubated in basal
medium with or without estrogen at 100ng mL−1. Addition
of estrogen elevated the secretion of cholesterol from the
tissue to 20μgm L −1 (Figure 5(a)). Addition of leptin to the
basal medium did not aﬀect the secretion of cholesterol to
the medium. Prolactin elevated the secretion of cholesterol
to 16μg mL per mg of tissue and the combination of leptin
at 100ng mL−1 and prolactin at 1μgm L −1 elevated the
secretion of cholesterol to its highest level of 19μgm L −1
per milligram of tissue. Addition of leptin antagonist to the
combined treatment of leptin and prolactin down-regulated
the secretion of cholesterol to 13.2μgm L −1 per milligram of
tissue (Figure 5(b)).
4. Discussion
The role of estrogen during bovine mammogenesis has been
well established [8]. Estrogen is essential for mammary
epithelial proliferationanddiﬀerentiation [9].Janowskietal.
[33], examined the mammary secretion of estrogen to
the mammary vein in lactating cows, found that around
parturition the plasma concentration of estrogen in the
abdominal vein was signiﬁcantly higher than that in the
peripheral blood. They also showed that lactating bovine
mammary tissue could convert andostendione to oestradiol-
17 beta; their ﬁndings clearly showed that the mammary
gland could produce and secrete estrogen, and that the level
of estrogen secretion from the mammary gland is correlated
with the levels of prolactin around parturition. Moreover,
Janowski et al. [33] found a correlation between the level
of estrogen secretion and high-yielding cows, which clearly
suggeststhatestrogenhasaroleintheregulationoflactation.
In the present study, we showed that estrogen aﬀected beta-
lactoglobulin expression in bovine mammary explants, and
that addition of estrogen to medium containing prolactin
and leptin up-regulated the expression of beta-lactoglobulin
in mammary explants to a higher level than that in
explants incubated with leptin and prolactin (Figure 1).
These ﬁndings are consistent with those of Janowski et al.
[33] regarding the lactogenic eﬀe c to fe s t r o g e no nb o v i n e
lactation. Previously, [20], we demonstrated that leptin had
the ability to up-regulate the lactogenic action of prolactin
in the lactating mammary gland. We also demonstrated that
the mammary fat has an essential role in the regulation of
leptin stimuli on prolactin lactogenic eﬀect [28]. Since, we
believe that estrogen in general, and mammary fat-derived
estrogen in particular, is involved in the regulation of bovine
lactation, we examined the expression of aromatase mRNA
in bovine mammary primary cells and bovine mammary fat.
We showed that prolactin could regulate aromatase mRNA
expression in mammary fat pad. We also show that prolactin
at a level of 1μg/mL can elevate the aromatase expression in
bovine mammary primary cell cultures (Figure 2). In light of
the present ﬁndings, it is suggested that prolactin regulates
estrogen secretion from the mammary gland and from the
mammary fat in particular.
Leptin is one of the factors that are secreted from the
mammary fat tissue. We hypothesize that the mammary fat-
derived leptin can regulate the action of estrogen on the
bovine mammary gland. Therefore, we examined the eﬀect
of leptin on ER alpha, and found that leptin regulated its’
expression in bovine mammary primary cells (Figure 3).
Earlier, we demonstrated the positive eﬀect of prolactin
stimulation of mammary fat explants on alpha casein
expression in bovine mammary explants and leptin secretion
from mammary fat explants [28]. Mammary fat explants in
the presences of prolactin up regulated the expression of ER
alpha in primary cell culture (Figure 4). When fat explants
were not present it the culture the expression of ER alpha did
not change dramatically compared to the incubation with fat
explants. Connor et al. [11] showed that ER alpha appeared
to be solely expressed in the mammary epithelial cells.
Our present ﬁnding, that leptin antagonist down regulated
the expression of ER alpha in mammary primary cells (as
shown in Figure 4) supports our hypothesis that leptin
regulates ER alpha expression. These ﬁndings are supported
by those of Catalano et al. [34], who demonstrated that






















































































Figure 5: Cholesterol secretion to the medium by mammary gland explants. (a) Eﬀect of estrogen on cholesterol secretion to the medium from
mammary explants culture. Bovine mammary explants from a lactating cow were incubated in medium containing insulin at 1μgm L −1,
with or without estrogen at 200ng mL−1. The secretion of cholesterol to the medium in which explants were incubated with insulin was
14.5 μgm L −1 per milligram of tissue; addition of estrogen to the medium containing insulin elevated the cholesterol secretion to level of
20μgm L −1 per milligram of tissue. Results are least squares means ± SE (n = 4). Bars with diﬀerent letters diﬀer at P < .05. (b) Eﬀects of
prolactin, leptin, and leptin antagonist on cholesterol secretion to the medium from mammary explants culture. Bovine mammary explants
from a lactating cow were incubated in medium with or without prolactin at 1μgm L −1, with or without leptin at 100ng mL−1,o rw i t ha
combinationofleptinat100ngmL−1 andprolactinat1μgmL −1,withorwithoutleptinantagonist.Additionofleptintothemediumdidnot
aﬀect the secretion of cholesterol to the medium. Prolactin at a concentration of 1μgm L −1 elevated the secretion of cholesterol 16μgm L −1
per milligram of tissue. A combination of leptin at 100ng mL−1 and prolactin at 1μgm L −1 elevated the secretion of cholesterol to its highest
level of 19μgm L −1 per milligram of tissue. Addition of leptin antagonist to the leptin plus prolactin combined treatment down-regulated
the secretion of cholesterol to 13.2μgm L −1 per milligram of tissue. Results are least squares means ± SE (n = 3). Bars with diﬀerent letters
diﬀer at P < .05.
in MCF-7 cells. We believe that the prolactin peak around
parturition induces the secretion of leptin and estrogen
from the mammary gland fat. Mammary-derived leptin
activates the ER alpha expression in the mammary gland,
and thus regulates the action of estrogen on the mammary
gland. Studies which examined the levels of leptin around
parturition showed that the concentration of leptin [35]a n d
leptin receptor [19] decreased near and after parturition.
These ﬁndings might contradict our hypothesis, however,
we believe that the level of leptin in the peripheral blood
does not reﬂect the activity of leptin within the secretory
mammary units. Moreover, the expression of leptin receptor
in ruminants after parturition was expressed mainly in the
mammaryalveolarepithelialcells[19],whichclearlysuggests
that leptin has a regulatory eﬀect on the alveolar unit. The
notion that leptin acts at the autocrine level is supported
by studies such as that of Silva [36], which showed that
the bovine mammary gland expresses the long form of
the leptin receptor (OB-Rb), and claimed that the local
concentration of leptin in the pre-pubertal mammary gland
might not be reﬂected in the leptin concentration in the
circulation. Additional support can be found in our previous
study [28], in which we demonstrated that addition of
leptin antagonist to an explants culture, that was incubated
only with prolactin, down-regulated the expression of beta-
lactoglobulin. This ﬁnding clearly indicates the involvement
of prolactin in the regulation of mammary-derived leptin
and leptin receptor in the bovine mammary explants. We
examined the eﬀect of estrogen on the secretion of total
cholesterol from explants culture and found that estrogen,
with or without prolactin, up-regulated the secretion of
cholesterol from lactating mammary gland explants to the
medium (Figure 5(a)). We also showed that prolactin could
up-regulate the secretion of cholesterol by the mammary
explants and that addition of leptin elevated the cholesterol
secretion to the medium. Leptin antagonist eliminated the
eﬀect of leptin on cholesterol secretion by the mammary
explants (Figure 5(b)) .P r e v i o u s l y ,w eh a v ed e m o n s t r a t e d
that leptin and prolactin up regulated the lactogenic markers
such as fatty acid synthesis and milk protein synthesis [20],
therefore it is not surprising that leptin and prolactin up
regulated the total cholesterol secretion from the bovine
mammary gland explants.
5. Conclusion
Based on all of the above we believe that the prolactin
peak around parturition activates an epithelial/mammary fat
interaction, which can aﬀect the potential milk yield. based
onalloftheabove,wesuggestthatthelevelofleptin,whichis
correlatedwiththe mammary fatmass, aﬀectsthe expression
of ER alpha in the epithelial mammary cells and thereby
regulates the eﬀect of mammary-derived estrogen on the
mammary gland.International Journal of Endocrinology 7
Acknowledgments
The authors thank professor A. Gertler for his generous gift
of bovine recombinant leptin, and leptin antagonist and
the Cattle Breeders’ Association of Israel for its ﬁnancial
support.
References
[1] A. Sch¨ aﬄer, U. M¨ uller-Ladner, J. Sch¨ olmerich, and C. B¨ uchler,
“Role of adipose tissue as an inﬂammatory organ in human
diseases,” Endocrine Reviews, vol. 27, no. 5, pp. 449–467, 2006.
[2] P.D.Walden,W.Ruan,M.Feldman,andD.L.Kleinberg,“Evi-
dencethatthemammaryfatpadmediatestheactionofgrowth
hormone in mammary gland development,” Endocrinology,
vol. 139, no. 2, pp. 659–662, 1998.
[3] R. W. Li, M. J. Meyer, C. P. van Tassell, et al., “Identiﬁcation
of estrogen-responsive genes in the parenchyma and fat
pad of the bovine mammary gland by microarray analysis,”
Physiological Genomics, vol. 27, no. 1, pp. 42–53, 2006.
[4] M. J. Meyer, A. V. Capuco, Y. R. Boisclair, and M. E. van
Amburgh, “Estrogen-dependent responses of the mammary
fat pad in prepubertal dairy heifers,” Journal of Endocrinology,
vol. 190, no. 3, pp. 819–827, 2006.
[5] D. Zangani, et al., “Adipocyte-epithelial interactions regulate
theinvitrodevelopmentofnormalmammaryepithelialcells,”
Experimental Cell Research, vol. 247, no. 2, pp. 399–409, 1999.
[ 6 ] R .C .H o v e y ,T .B .M c F a d d e n ,a n dR .M .A k e r s ,“ R e g u l a t i o no f
mammaryglandgrowthandmorphogenesisbythemammary
fat pad: a species comparison,” Journal of Mammary Gland
Biology and Neoplasia, vol. 4, no. 1, pp. 53–68, 1999.
[7] W. R. Lyons, “Hormonal synergism in mammary growth,”
Proceedings of the Royal Society B, vol. 149, no. 936, pp. 303–
325, 1958.
[8] W. Ruan, V. Catanese, R. Wieczorek, M. Feldman, and D.
L. Kleinberg, “Estradiol enhances the stimulatory eﬀect of
insulin-like growth factor-I (IGF-I) on mammary develop-
ment and growth hormone-induced IGF-I messenger ribonu-
cleicacid,”Endocrinology,vol.136,no.3,pp.1296–1302,1995.
[9] Y. J. Topper and C. S. Freeman, “Multiple hormone interac-
tions in the developmental biology of the mammary gland,”
Physiological Reviews, vol. 60, no. 4, pp. 1049–1106, 1980.
[10] D. Schams, S. Kohlenberg, W. Amselgruber, B. Berisha, M.
W. Pfaﬄ, and F. Sinowatz, “Expression and localisation of
oestrogen and progesterone receptors in the bovine mammary
gland during development, function and involution,” Journal
of Endocrinology, vol. 177, no. 2, pp. 305–317, 2003.
[11] E. E. Connor, D. L. Wood, T. S. Sonstegard, et al., “Chro-
mosomal mapping and quantitative analysis of estrogen-
relatedreceptoralpha-1,estrogenreceptorsalphaandbetaand
progesterone receptor in the bovine mammary gland,” Journal
of Endocrinology, vol. 185, no. 3, pp. 593–603, 2005.
[12] L. Vignozzi, S. Filippi, M. Luconi, et al., “Oxytocin receptor
is expressed in the penis and mediates an estrogen-dependent
smooth muscle contractility,” Endocrinology, vol. 145, no. 4,
pp. 1823–1834, 2004.
[13] T. Janowski, S. Zdu´ nczyk, A. Ra´ s, and S. Okrasa, “Mammary
secretion of oestrogens and prostaglandin F2α in cows near
parturition,” Animal Reproduction Science,v o l .1 7 ,n o .3 - 4 ,p p .
297–302, 1988.
[14] G. Shyamala, Y.-C. Chou, S. G. Louie, R. C. Guzman, G. H.
Smith, and S. Nandi, “Cellular expression of estrogen and
progesterone receptors in mammary glands: regulation by
hormones, development and aging,” Journal of Steroid Bio-
chemistry and Molecular Biology, vol. 80, no. 2, pp. 137–148,
2002.
[15] M. Bonnet, I. Gourdou, C. Leroux, Y. Chilliard, and J.
Djiane, “Leptin expression in the ovine mammary gland:
putative sequential involvement of adipose, epithelial, and
myoepithelial cells during pregnancy and lactation,” Journal of
Animal Science, vol. 80, no. 3, pp. 723–728, 2002.
[16] L. A. Tartaglia, M. Dembski, X. Weng, et al., “Identiﬁcation
and expression cloning of a leptin receptor, OB-R,” Cell, vol.
83, no. 7, pp. 1263–1271, 1995.
[17] N. Yanagihara, K. Utsunomiya, T. B. Cheah, et al., “Character-
izationandfunctionalroleofleptinreceptorinbovineadrenal
medullary cells,” Biochemical Pharmacology,v o l .5 9 ,n o .9 ,p p .
1141–1145, 2000.
[18] P. K. Chelikani, D. R. Glimm, and J. J. Kennelly, “Short com-
munication: tissue distribution of leptin and leptin receptor
mRNA in the bovine,” Journal of Dairy Science, vol. 86, no. 7,
pp. 2369–2372, 2003.
[19] K. Laud, I. Gourdou, L. B´ elair, D. H. Keisler, and J. Djiane,
“Detection and regulation of leptin receptor mRNA in ovine
mammary epithelial cells during pregnancy and lactation,”
FEBS Letters, vol. 463, no. 1-2, pp. 194–198, 1999.
[20] Y. Feuermann, S. J. Mabjeesh, and A. Shamay, “Leptin aﬀects
prolactinactiononmilkproteinandfatsynthesisinthebovine
mammary gland,” Journal of Dairy Science, vol. 87, no. 9, pp.
2941–2946, 2004.
[21] F. M. Gregoire, “Adipocyte diﬀerentiation: from ﬁbroblast to
endocrine cell,” Experimental Biology and Medicine, vol. 226,
no. 11, pp. 997–1002, 2001.
[22] D. Fleenor, R. Arumugam, and M. Freemark, “Growth
hormone and prolactin receptors in adipogenesis: STAT-5
activation, suppressors of cytokine signaling, and regulation
of insulin-like growth factor I,” Hormone Research, vol. 66, no.
3, pp. 101–110, 2006.
[23] H. C. Mertani, T. Garcia-Caballero, A. Lambert, et al., “Cellu-
lar expression of growth hormone and prolactin receptors in
human breast disorders,” International Journal of Cancer, vol.
79, no. 2, pp. 202–211, 1998.
[ 2 4 ]T .B .M c F a d d e n ,T .E .D a n i e l ,a n dR .M .A k e r s ,“ E ﬀects
of plane of nutrition, growth hormone and unsaturated
fat on growth hormone, insulin and prolactin receptors in
prepubertal lambs,” Journal of Animal Science, vol. 68, no. 10,
pp. 3180–3189, 1990.
[25] P. A. Accorsi, N. Govoni, R. Gaiani, C. Pezzi, E. Seren,
and C. Tamanini, “Leptin, GH, PRL, insulin and metabolic
parameters throughout the dry period and lactation in dairy
cows,” Reproduction in Domestic Animals,v o l .4 0 ,n o .3 ,p p .
217–223, 2005.
[26] L. Niv-Spector, D. Gonen-Berger, I. Gourdou, et al., “Identiﬁ-
cation of the hydrophobia strand in the A-B loop of leptin as
major binding site III: implications for large-scale preparation
of potent recombinant human and ovine leptin antagonists,”
Biochemical Journal, vol. 391, no. 2, pp. 221–230, 2005.
[27] A. Shamay, E. Zeelon, and Z. Ghez, “Inhibition of casein and
fat synthesis and α-lactalbumin secretion by progesterone in
explants from bovine lactating mammary glands,” Journal of
Endocrinology, vol. 113, no. 1, pp. 81–88, 1987.
[28] Y. Feuermann, S. J. Mabjeesh, L. Niv-Spector, D. Levin, and
A. Shamay, “Prolactin aﬀects leptin action in the bovine
mammary gland via the mammary fat pad,” Journal of
Endocrinology, vol. 191, no. 2, pp. 407–413, 2006.
[29] G. Schuler, C. Wirth, U. Teichmann, et al., “Occurrence of
estrogen receptor α in bovine placentomes throughout mid8 International Journal of Endocrinology
and late gestation and at parturition,” Biology of Reproduction,
vol. 66, no. 4, pp. 976–982, 2002.
[30] N. Argov, U. Moallem, and D. Sklan, “Summer heat stress
alters the mRNA expression of selective-uptake and endocy-
toticreceptorsinbovineovariancells,”Theriogenology,vol.64,
no. 7, pp. 1475–1489, 2005.
[31] P. Chomczynski and N. Sacchi, “Single-step method of
RNA isolation by acid guanidinium thiocyanate-phenol-
chloroform extraction,” Analytical Biochemistry, vol. 162, no.
1, pp. 156–159, 1987.
[32] SAS Institute, SAS User’s Guide: Statistics, SAS Institute, Cary,
NC, USA, 2001.
[33] T. Janowski, S. Zdu´ nczyk, J. Małecki-Tepicht, W. Bara´ nski,
and A. Ra´ s, “Mammary secretion of oestrogens in the cow,”
Domestic Animal Endocrinology, vol. 23, no. 1-2, pp. 125–137,
2002.
[34] S. Catalano, L. Mauro, S. Marsico, et al., “Leptin induces, via
ERK1/ERK2 signal, functional activation of estrogen receptor
αinMCF-7cells,”TheJournalofBiologicalChemistry,vol.279,
no. 19, pp. 19908–19915, 2004.
[35] A. Meikle, M. Kulcsar, Y. Chilliard, et al., “Eﬀects of parity and
body condition at parturition on endocrine and reproductive
parameters of the cow,” Reproduction, vol. 127, no. 6, pp. 727–
737, 2004.
[36] L. F. P. Silva, M. J. VandeHaar, M. S. Weber Nielsen, and
G. W. Smith, “Evidence for a local eﬀe c to fl e p t i ni nb o v i n e
mammary gland,” Journal of Dairy Science, vol. 85, no. 12, pp.
3277–3286, 2002.